FDA Reconsiders ORA Reorganization As Questions From Congress Continue
This article was originally published in The Tan Sheet
Executive Summary
FDA's Aug. 1 decision to temporarily suspend plans to close seven of its 13 field laboratories as part of its Office of Regulatory Affairs reorganization follows repeated protests and inquiries from Capitol Hill, including a July 31 letter from two of the proposal's chief critics